Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kasim Kutay Insider Profile
4 Followers
Kasim Kutay, Director at Novo Nordisk, holds 177.56M shares in Novo Nordisk (Ticker: GB:0QIU), holds 395.32M shares in ConvaTec (Ticker: GB:CTEC). Most recently, Kasim Kutay Sold ― shares of Novo Nordisk on Nov 08, 2024 for an estimated value of 4.74B.
Profitable Transactions
14 out of 32 Profitable Transactions
Average Return
-4.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Kasim Kutay holds in companies
Most Profitable Insider Trade
The most profitable trade made by Kasim Kutay
Kasim Kutay's Trading History
Novo Nordisk
Nov 08, 2024
Director
Informative Sell
4.74B
kr129.61B
ConvaTec
May 08, 2018
Director, Ten Percent Owner
Informative Buy
13.44M
£921.09M
List of latest transactions for each holding click on a transaction to see Kasim Kutay's performance on stock
You May Also Like
Kasim Kutay insider profile FAQ
What is the percentage of profitable transactions made by Kasim Kutay?
The percentage of profitable transactions made by Kasim Kutay is 44%.
What is the average return per transaction made by Kasim Kutay?
The average return per transaction made by Kasim Kutay is -4.70%.
What stocks does Kasim Kutay hold?
Kasim Kutay holds: GB:0QIU, GB:CTEC stocks.
What was Kasim Kutay’s latest transaction?
Kasim Kutay latest transaction was an Informative Sell of kr4.74B.
What was Kasim Kutay's most profitable transaction?
Kasim Kutay’s most profitable transaction was an Informative Buy of GB:0QIU stock on February 2, 2023. The return on the trade was 26.30%.
What is Kasim Kutay's role in Novo Nordisk?
Kasim Kutay's role in Novo Nordisk is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.